ERBB2 and breast carcinoma: As another illustration of MNPs for cancer detection, Shamsipura et al. described an immunosensor based on Fe3O4-secondary antibody (Ab2) bioconjugates for the specific detection of human epidermal growth factor receptor 2 (HER2), an important biomarker of oncogenic treatment for breast cancer.